Latest Spinal muscular atrophy Stories
CARLSBAD, Calif., April 30, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Results presented at the American Academy of Neurology meeting CARLSBAD, Calif., April 29, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Each winner receives $27,500 for Spinal Muscular Atrophy (SMA) research. Washington, DC (PRWEB) April 11, 2014 Two organizations dedicated to defeating
-Conference Call Today at 4:30 pm ET- SOUTH PLAINFIELD, N.J., March 6, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
These funds were awarded as part of Families of SMA’s basic research grant program.
On track to initiate Phase 3 study in infants with SMA in the middle of this year CARLSBAD, Calif., Feb. 21, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx CARLSBAD, Calif., Feb.
--Isis will receive $9.3 million in milestone payments -- CARLSBAD, Calif., Feb. 13, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Use of Genetic Variants Improves Detection of SMA Carriers in Clinical Test that will be Broadly Licensed to Testing Labs Worldwide New York, NY (PRWEB) February
Program Created by FightSMA and Gwendolyn Strong Foundation to Advance Spinal Muscular Atrophy Research Washington, DC (PRWEB) January 22, 2014 The "FightSMA
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.